References

• 2014Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide10,521 cited
• 2022Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20196,444 cited
• 2021Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic5,433 cited
• 2016Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses3,063 cited
• 2017CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts1,531 cited
• 1999The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of Health-Related Quality of Life787 cited
• 2014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials670 cited
• 2016Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial595 cited
• 2017Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries556 cited
• 2001The death of cost‐minimization analysis?437 cited
• 2012Estimating remission from untreated major depression: a systematic review and meta-analysis376 cited
• 2023Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patients